Global Gastric Cancer Market Set for Further Growth, States Koncept Analytics in Its Report Published at

13 Jun 2016 • by Natalie Aster

LONDON – The global gastric cancer market is driven by some factors, as growing spending on targeted cancer therapies. Population ageing and increasing spending on oncology drugs are other drivers. Rising consumption of cigarettes and growth of the male population are some other important forces that drive the growth.

However, the marketplace has to deal with some challenges, with new targeted therapies’ low penetration being one of the key ones.

Some of major trends seen currently in this market comprise, and a gradual shift of focus towards targeted therapies is amongst them.

This marketplace is ruled by such players as AstraZeneca, Merck & Co., Roche Holdings, to name a few.

Topical research study “Global Gastric Cancer Market Report: 2016 Edition” drawn up by Koncept Analytics offers a comprehensive discussion of the world’s gastric cancer market state. The report includes a detailed overview of the disease and global marketplace. It focuses on treatment options and covers disease prevalence in detail.

The study examines the market on the basis of value and casts light on regional marketplaces, besides paying attention to major countries. The research report explores dynamics of this marketplace and delves deep into its competitive environment. It also contains major players’ profiles.

Report Highlights:

  • 360-degree view of the market;
  • detailed coverage of the disease;
  • analysis of the marketplace on a global, regional and country level;
  • insights into market dynamics;
  • exploration of the competitive landscape;
  • top players’ profiles;
  • and more.

Other Global Marketplaces Investigated by the Publisher Include:

More insightful studies by Koncept Analytics are available at its page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970